Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Barrett Esophagus × Docosahexaenoic Acids × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Gastrointestinal 1

Conditions

Obesity 4 Polycystic Ovary Syndrome 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Overweight 1 Non-alcoholic Fatty Liver Disease 1 Lipid Metabolism Disorders 1 Diabetes Mellitus 1 Cardiovascular Diseases 1 Barrett Esophagus 1

Interventions

Docosahexaenoic Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01733147 2022-01-11

Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids

Mayo Clinic

Phase 4 Completed

60 enrolled 6 charts

GastrointestinalOther

Barrett Esophagus, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡